FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1992810156> ?p ?o ?g. }

• W1992810156 endingPage "240" @default.
• W1992810156 startingPage "236" @default.
• W1992810156 abstract "Background The endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine (ADMA) and total homocysteine (tHcy) are elevated in patients at increased cardiovascular risk. Patients with type 2 diabetes (T2DM) have higher incidence of macrovascular disease than the general population. Recent reports suggest a relationship between tHcy and ADMA. To evaluate the connection between ADMA and tHcy and macrovascular disease, we determined both risk factors in T2DM patients with and without macrovascular disease. Subjects and methods Plasma concentrations of ADMA and tHcy were cross-sectionally determined in 136 T2DM patients. Fifty-five patients had macrovascular disease defined by history of stroke, myocardial infarction, coronary heart disease or peripheral arterial occlusive disease. Logistic regression analysis was performed to examine the relationship between macrovascular disease and these risk factors. Potential confounders were identified by significant Spearman rank correlation coefficients. Results In unadjusted models ADMA (per 0.1 μmol/l) and tHcy (per 5 μmol/l) were both significantly related to macrovascular disease (OR = 1.63, 95% CI: 1.21–2.19 and OR = 1.49, 95% CI: 1.04–2.14). In multivariate models, ADMA was significantly associated with macrovascular disease independent of l-arginine, albumin excretion rate, tHcy and glomerular filtration rate (GFR; OR = 1.53, 95% CI: 1.04–2.26). The connection between tHcy and macrovascular disease was not independent of diastolic blood pressure, age, ADMA or GFR. Linear regression analyses revealed that ADMA, GFR and low-density lipoprotein cholesterol were independent predictors for tHcy. Conclusion ADMA is associated with macrovascular disease independent of tHcy and traditional cardiovascular risk factors in patients with T2DM." @default.
• W1992810156 created "2016-06-24" @default.
• W1992810156 creator A5017491951 @default.
• W1992810156 creator A5048027389 @default.
• W1992810156 creator A5054404247 @default.
• W1992810156 creator A5056493667 @default.
• W1992810156 creator A5070087656 @default.
• W1992810156 creator A5074841111 @default.
• W1992810156 creator A5080203540 @default.
• W1992810156 date "2006-11-01" @default.
• W1992810156 modified "2023-09-25" @default.
• W1992810156 title "Asymmetric dimethylarginine is associated with macrovascular disease and total homocysteine in patients with type 2 diabetes" @default.
• W1992810156 cites W112879263 @default.
• W1992810156 cites W1980582672 @default.
• W1992810156 cites W1983481492 @default.
• W1992810156 cites W1999255023 @default.
• W1992810156 cites W2017813736 @default.
• W1992810156 cites W2051220082 @default.
• W1992810156 cites W2052240447 @default.
• W1992810156 cites W2055864845 @default.
• W1992810156 cites W2058385357 @default.
• W1992810156 cites W2070692648 @default.
• W1992810156 cites W2078608838 @default.
• W1992810156 cites W2080105057 @default.
• W1992810156 cites W2089231782 @default.
• W1992810156 cites W2091329460 @default.
• W1992810156 cites W2093943353 @default.
• W1992810156 cites W2106478344 @default.
• W1992810156 cites W2107818859 @default.
• W1992810156 cites W2119348567 @default.
• W1992810156 cites W2122875042 @default.
• W1992810156 cites W2140179588 @default.
• W1992810156 cites W2148531805 @default.
• W1992810156 cites W2166937516 @default.
• W1992810156 cites W2169513794 @default.
• W1992810156 cites W2170635325 @default.
• W1992810156 cites W2170703297 @default.
• W1992810156 cites W2342150662 @default.
• W1992810156 cites W355972819 @default.
• W1992810156 cites W4239198672 @default.
• W1992810156 doi "https://doi.org/10.1016/j.atherosclerosis.2005.12.007" @default.
• W1992810156 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16414052" @default.
• W1992810156 hasPublicationYear "2006" @default.
• W1992810156 type Work @default.
• W1992810156 sameAs 1992810156 @default.
• W1992810156 citedByCount "61" @default.
• W1992810156 countsByYear W19928101562012 @default.
• W1992810156 countsByYear W19928101562013 @default.
• W1992810156 countsByYear W19928101562014 @default.
• W1992810156 countsByYear W19928101562015 @default.
• W1992810156 countsByYear W19928101562017 @default.
• W1992810156 countsByYear W19928101562018 @default.
• W1992810156 countsByYear W19928101562019 @default.
• W1992810156 countsByYear W19928101562021 @default.
• W1992810156 countsByYear W19928101562022 @default.
• W1992810156 countsByYear W19928101562023 @default.
• W1992810156 crossrefType "journal-article" @default.
• W1992810156 hasAuthorship W1992810156A5017491951 @default.
• W1992810156 hasAuthorship W1992810156A5048027389 @default.
• W1992810156 hasAuthorship W1992810156A5054404247 @default.
• W1992810156 hasAuthorship W1992810156A5056493667 @default.
• W1992810156 hasAuthorship W1992810156A5070087656 @default.
• W1992810156 hasAuthorship W1992810156A5074841111 @default.
• W1992810156 hasAuthorship W1992810156A5080203540 @default.
• W1992810156 hasConcept C126322002 @default.
• W1992810156 hasConcept C134018914 @default.
• W1992810156 hasConcept C159641895 @default.
• W1992810156 hasConcept C164705383 @default.
• W1992810156 hasConcept C185592680 @default.
• W1992810156 hasConcept C2777090595 @default.
• W1992810156 hasConcept C2777180221 @default.
• W1992810156 hasConcept C2777468819 @default.
• W1992810156 hasConcept C2778848681 @default.
• W1992810156 hasConcept C2779877776 @default.
• W1992810156 hasConcept C515207424 @default.
• W1992810156 hasConcept C55493867 @default.
• W1992810156 hasConcept C555293320 @default.
• W1992810156 hasConcept C71924100 @default.
• W1992810156 hasConcept C77350462 @default.
• W1992810156 hasConcept C90924648 @default.
• W1992810156 hasConceptScore W1992810156C126322002 @default.
• W1992810156 hasConceptScore W1992810156C134018914 @default.
• W1992810156 hasConceptScore W1992810156C159641895 @default.
• W1992810156 hasConceptScore W1992810156C164705383 @default.
• W1992810156 hasConceptScore W1992810156C185592680 @default.
• W1992810156 hasConceptScore W1992810156C2777090595 @default.
• W1992810156 hasConceptScore W1992810156C2777180221 @default.
• W1992810156 hasConceptScore W1992810156C2777468819 @default.
• W1992810156 hasConceptScore W1992810156C2778848681 @default.
• W1992810156 hasConceptScore W1992810156C2779877776 @default.
• W1992810156 hasConceptScore W1992810156C515207424 @default.
• W1992810156 hasConceptScore W1992810156C55493867 @default.
• W1992810156 hasConceptScore W1992810156C555293320 @default.
• W1992810156 hasConceptScore W1992810156C71924100 @default.
• W1992810156 hasConceptScore W1992810156C77350462 @default.
• W1992810156 hasConceptScore W1992810156C90924648 @default.
• W1992810156 hasIssue "1" @default.
• W1992810156 hasLocation W19928101561 @default.

• next